Glenmark Life Sciences Ltd - Closure of Trading Window

We wish to inform you that, the Company has intimated its "designated persons" regarding the closure of trading window from June 30, 2024, to July 27, 2024 (both days inclusive) for the purpose of approval of Unaudited Financial Results for the first quarter ended June 30, 2024.